The Scottish Fold’s characteristic ear is caused by a cartilage defect, and the same defect affects cartilage throughout the body. Osteochondrodysplasia produces thickened, malformed bones and joints, progressive arthritis, and a stiff, painful gait. It is not a possibility in folded cats. It is the mechanism that creates the fold.
Inheritance and severity
The trait is autosomal dominant with incomplete penetrance. A cat with two copies (homozygous fold) develops severe skeletal disease early, often within months. A cat with one copy develops milder disease later, but still develops it.
Breeding a fold to a non-fold produces heterozygous kittens; breeding two folds produces homozygous kittens with the severe form. Responsible registries restrict or prohibit fold-to-fold matings for this reason.
Clinical signs and diagnosis
Signs include a stiff tail, reluctance to jump, thickened limbs, swollen joints and a crouched stance. Radiography shows characteristic bony exostoses and shortened, deformed metacarpals and phalanges; a full skeletal series costs $300 to $600.
Because the disease is progressive, monitoring is radiographic and clinical rather than curative. There is no treatment that reverses the cartilage abnormality.
| Item | Typical cost | Frequency |
|---|---|---|
| Skeletal radiography | $300–$600 | At diagnosis, then periodically |
| Lifelong analgesia | $40–$150/month | Ongoing |
| Monitoring bloodwork | $150–$300 | Twice yearly |
| Physiotherapy | $50–$100/session | As needed |
| Advanced imaging (CT) | $800–$1,500 | Selected cases |
Lifetime cost of management
Pain management is lifelong: NSAIDs or monoclonal antibody therapy, joint supplements, and often physiotherapy. Monthly cost commonly runs $40 to $150, rising with age.
Severe cases require multimodal analgesia and periodic bloodwork to monitor kidney and liver function, which adds $150 to $300 twice a year. Some cats eventually need amputation in the most severely affected limbs, though this is uncommon.
Insurance reality for the breed
Because osteochondrodysplasia is congenital and breed-defining, most insurers exclude it outright, either by naming the condition or by applying a congenital/hereditary exclusion that the fold automatically triggers.
Some carriers decline Scottish Folds for new business entirely. Others accept them with an explicit skeletal exclusion. If you own a Fold, assume the breed-defining condition is not insurable and insure for everything else.
- Every folded cat carries the cartilage mutation.
- Homozygous folds develop severe disease within months.
- Pain management is lifelong and progressive.
- Most insurers exclude the condition as congenital or breed-defining.
A congenital exclusion does not need to name osteochondrodysplasia. If the policy excludes congenital conditions, the fold itself is the evidence. Read that clause before assuming skeletal cover exists.
Key takeaways
- The fold and the disease share one mechanism.
- Severity depends on whether the cat carries one or two copies.
- Management is lifelong analgesia, not surgery.
- Congenital exclusions remove skeletal cover for the breed.
